← back to search

Dwarakanathan Ranganathan

Griffith University · AU
Area of research
Nephrology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Dialysis and Renal Disease Management, Renal Diseases and Glomerulopathies, Vasculitis and related conditions, and Chronic Kidney Disease and Diabetes.
h-index
22
citations
1,806
works
117
NIH funding
primary concept
email

Recent publications

Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland
Australian Journal of Rural Health 2024cited by 4position: middledoi
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial
Annals of the Rheumatic Diseases 2023cited by 113position: middledoi
Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan
Kidney International Reports 2023cited by 80position: middledoi
The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
The Lancet Rheumatology 2023cited by 29position: middledoi
Clinical and economic burden of benign and malignant skin lesions in renal transplant recipients
Internal Medicine Journal 2023cited by 6position: middledoi
#5344 EPIDEMIOLOGY OF GLOMERULAR DISEASES IN THE PRE- AND POST-COVID-19 ERA IN CENTRAL QUEENSLAND, AUSTRALIA
Nephrology Dialysis Transplantation 2023cited by 1position: lastdoi
#2754 EPIDEMIOLOGY OF PAUCI-IMMUNE ANCA-ASSOCIATED GLOMERULONEPHRITIS – REPORT FROM AN AUSTRALIAN POPULATION-BASED STUDY
Nephrology Dialysis Transplantation 2023cited by 1position: lastdoi
Critical evaluation of cancer risks in glomerular disease
Translational Oncology 2022cited by 9position: middledoi
An integrated skin cancer education program in renal transplant recipients and patients with glomerular disease
BMC Nephrology 2022cited by 9position: middledoi
Reducing<scp>non‐melanoma</scp>skin cancer risk in renal transplant recipients
Nephrology 2021cited by 10position: middledoi
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
Annals of the Rheumatic Diseases 2020cited by 172position: middledoi
Comparison of skin cancer awareness and sun protection behaviours between renal transplant recipients and patients with glomerular disease treated with immunosuppressants
Nephrology 2020cited by 10position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tien K. Khoo · University of Edinburgh8 papers (2020–2024)Alfred K. Lam · Addenbrooke's Hospital8 papers (2020–2024) · 7 papers (2020–2024)Zaw Thet · Griffith University7 papers (2020–2024)Shu‐Kay Ng · McGill University Health Centre6 papers (2020–2024) · 4 papers (2021–2024) · 3 papers (2020–2024) · 2 papers (2023–2024) · 2 papers (2020–2022) · 2 papers (2020–2022) · 2 papers (2023–2023) · 2 papers (2022–2024)Jason C. Steel · Center for Cancer Research1 papers (2023–2023)George John · University of Queensland1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2023–2023)Tony Pham · University of South Florida1 papers (2023–2023) · 1 papers (2023–2023)